Cellphire Revenue and Competitors

Location

$16M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Cellphire's estimated annual revenue is currently $12.7M per year.(i)
  • Cellphire's estimated revenue per employee is $155,000
  • Cellphire's total funding is $16M.

Employee Data

  • Cellphire has 82 Employees.(i)
  • Cellphire grew their employee count by 11% last year.

Cellphire's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
CEOReveal Email/Phone
4
CEO & PresidentReveal Email/Phone
5
Chief Medical OfficerReveal Email/Phone
6
VP Discovery ResearchReveal Email/Phone
7
VP, Cryopreserved Platelets & Capital SupportReveal Email/Phone
8
VP Business OperationsReveal Email/Phone
9
VP Strategy & Investor Relations, Corporate SecretaryReveal Email/Phone
10
EVP R&D and OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M20%N/AN/A
#2
$3.6M46-31%$17.5MN/A
#3
$3.6M46-34%$10.5MN/A
#4
$30.2M1560%$69.4MN/A
#5
$11.8M76-15%N/AN/A
#6
$1.7M110%N/AN/A
#7
$2.5M160%N/AN/A
#8
$8.8M5719%N/AN/A
#9
$0.2M1-86%N/AN/A
#10
$2M1318%N/AN/A
Add Company

What Is Cellphire?

Cellphire Therapeutics, Inc. is a Rockville, Maryland-based biotechnology company developing next-generation therapeutics. The company is applying its proprietary cell stabilization technology to all cell types, including platelets, to develop lifesaving products. Its lead product, Thrombosomes®, a freeze-dried hemostatic agent derived from human platelets, is currently in a Phase I clinical trial. Cellphire's technology has potential applications across a wide range of medical applications from trauma to wound care, imaging, targeted drug delivery, and regenerative medicine.

keywords:N/A

$16M

Total Funding

82

Number of Employees

$12.7M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cellphire News

2022-04-20 - Radiation Toxicity (Radiation Sickness, Acute Radiation ...

Aeolus Pharmaceuticals, Atox Bio Ltd, BCN Biosciences LLC, Cellphire Inc, Daiichi Sankyo Co Ltd, FirstString Research Inc, RxBio Inc,...

2022-03-22 - Cellphire Therapeutics Treats First Patient in Phase 2/3 ...

Cellphire Therapeutics, Inc. is a biotechnology company developing next-generation allogeneic cellular therapeutics. The company is applying its...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$17.2M82-7%N/A
#2
$12M8341%N/A
#3
$12.2M845%N/A
#4
$12.2M84N/AN/A
#5
$15M854%N/A